Publication | Closed Access

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease☆

Surgical OncologyGynecological SurgeryNeoadjuvant ChemotherapyAdvanced Ovarian CancerMedicineCancer ManagementGynecologySurgeryStage Iv Disease☆Cancer TreatmentOncologyGynecology OncologyOvarian Cancer